Adherence to Overactive Bladder Syndrome Treatments Recent Developments and Future Perspectives
Dudley Robinson, Miriam O’Kane, Linda Cardozo Department of Urogynaecology, King’s College Hospital, London, UKCorrespondence: Dudley Robinson, Department of Urogynaecology, King’s College Hospital, Suite 8, Level 3, Golden Jubilee Wing, London, SE5 9RS, UK, Tel +447966485503, Email dudley.robinson@...
Main Authors: | Robinson D, O'Kane M, Cardozo L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-05-01
|
Series: | International Journal of Women's Health |
Subjects: | |
Online Access: | https://www.dovepress.com/adherence-to-overactive-bladder-syndrome-treatments-recent-development-peer-reviewed-fulltext-article-IJWH |
Similar Items
-
Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder
by: Roger R. Dmochowski, et al.
Published: (2023-04-01) -
Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients
by: Yuh-Chen Kuo, et al.
Published: (2023-01-01) -
Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
by: Ömer Acar, et al.
Published: (2019-06-01) -
Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis
by: Michael Kennelly, et al.
Published: (2022-10-01) -
Comparative persistence, switch rates, and predictors for discontinuation of antimuscarinics for overactive bladder: A 10-year nationwide population-based study in Taiwan
by: Hao-Wei Chen, et al.
Published: (2018-01-01)